The importance of molecular cytogenetic analysis prior to using cell lines in research: The case of the KG-1a leukemia cell line
- Authors:
- Franca Pelliccia
- Valentina Ubertini
- Nazario Bosco
View Affiliations
Affiliations: Department of Biology and Biotechnology, Sapienza University, I-00185 Rome, Italy, The Rockefeller University, New York, NY 10065, USA
- Published online on: May 9, 2012 https://doi.org/10.3892/ol.2012.709
-
Pages:
237-240
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
KG-1 and its less differentiated subline KG-1a are leukemia cell lines used in research in a number of laboratories. The karyotypes of the two lines were initially identical. In the following years, further analysis revealed that the cell lines had acquired additional karyotypical abnormalities and differed in the presence of certain typical chromosomal rearrangements. To obtain cytogenetic authentication prior to the use of the two cell lines, we analyzed their karyotype by combining DAPI- and CMA-chromosome bandings and a fluorescence in situ hybridization (FISH)-based approach by using BAC clones useful for the identification of chromosome regions of interest. Sequences of the MYC, PLZF, RARA and BCR genes, that are known to play a critical role in leukemogenesis, and certain BAC clones mapped to five known common fragile sites (CFS) were used for the FISH analysis. A telomeric probe (TTAGGG)n and a set of BAC clones were used to characterize the marker chromosome der(1) that was observed in the cell line KG-1a. The existence of notable differences between the karyotype of the KG-1a cell line previously described, and that described in this study, demonstrate that the use of established cancer cell lines should be preceded by cytogenetic and/or molecular characterization.
View References
|
1
|
Koeffler HP and Golde DW: Acute
myelogenous leukemia: a human cell line responsive to
colony-stimulating activity. Science. 200:1153–1154. 1978.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Koeffler HP, Billing R, Lusis AJ, et al:
An undifferentiated variant derived from the human acute
myelogenous leukemia cell line (KG-1). Blood. 56:265–273.
1980.PubMed/NCBI
|
|
3
|
Furley AJ, Reeves BR, Mizutani S, et al:
Divergent molecular phenotypes of KG1 and KG1a myeloid cell lines.
Blood. 68:1101–1107. 1986.PubMed/NCBI
|
|
4
|
Mrózek K, Tanner SM, Heinonen K and
Bloomfield CD: Molecular cytogenetic characterization of the KG-1
and KG-1a acute myeloid leukemia cell lines by use of spectral
karyotyping and fluorescence in situ hybridization. Genes
Chromosomes Cancer. 38:249–252. 2003.PubMed/NCBI
|
|
5
|
Jones L, Wei G, Sevcikova S, et al: Gain
of MYC underlies recurrent trisomy of the MYC chromosome in acute
promyelocytic leukemia. J Exp Med. 207:2581–2594. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guidez F, Parks S, Wong H, et al:
RARalpha-PLZF overcomes PLZF-mediated repression of CRABPI,
contributing to retinoid resistance in t(11;17) acute promyelocytic
leukemia. Proc Natl Acad Sci USA. 104:18694–18699. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Arlt MF, Casper AM and Glover TW: Common
fragile sites. Cytogenet Genome Res. 100:92–100. 2003. View Article : Google Scholar
|
|
8
|
Ijdo WJ, Wells RA, Baldini A and Reeders
ST: Improved telomere detection using a telomere repeat probe
(TTAGGG)n generated by PCR. Nucleic Acids Res. 19:47801991.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pelliccia F, Bosco N and Rocchi A:
Breakages at common fragile sites set boundaries of amplified
regions in two leukemia cell lines K562 - Molecular
characterization of FRA2H and localization of a new CFS FRA2S.
Cancer Lett. 299:37–44. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dessen P, Knuutila S and Huret JL:
Chromosome. Atlas Cytogenet Oncol Haematol. Jul. 2004, Updated
2010. http://AtlasGeneticsOncology.org.
|
|
11
|
Hughes P, Marshall D, Reid Y, et al: The
costs of using unauthenticated, over-passaged cell lines: how much
more data do we need? Biotechniques. 43:575–586. 2007. View Article : Google Scholar : PubMed/NCBI
|
